In May 2026, Dexcom disclosed FDA-enforced, Class II voluntary recalls of its G7 and ONE/ONE+ iOS and watchOS apps worldwide due to a software defect that can…
Updated Jun 2, 2026
Upgrade to a paid plan to see AI rating history on the chart.
In May 2026, Dexcom disclosed FDA-enforced, Class II voluntary recalls of its G7 and ONE/ONE+ iOS and watchOS apps worldwide due to a software defect that can…
They have outpaced the S&P 500 over the past 10 years.
Tandem Diabetes' Q1 beat, fatter margins and positive cash flow fuel its 2026 reset as it shifts more U.S. pump starts to pay-as-you-go pharmacy.
SAN DIEGO, June 02, 2026--Dexcom, Inc., the global leader in glucose biosensing, today released its inaugural Customer Advisory Council Report, detailing candi…
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQUjNkOFY1eElyWW52eW84X09ET2N1UEEyaGU5bmkxcmpRMF8xb2NVM0VNN2FUaF9nSlMyWDNLN0FBQjY0SUdXUXJpNVZhX1hTM…
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9OdDhWRzZDaTVTUFNFZkYzZ01sS2RxcVp4dTE0Q1pZTzlTNHlJZ00wd0s0MnJVYTZSdjNrWFI1Ulg1ZmJGTGVManhWRWZGSVI2c…
SAN FRANCISCO, May 28, 2026--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Bene…
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPaU9QOEdfNmp0MFM4dlJ3YTJrdUt1YmhUaktPQ0hhRUZ4TkhLdHlVRW9JZExUT1ZBWnJTR3BzdUkyV1hjVmdsY2drNlJzRmJVc…
Not investment advice. Past performance does not guarantee future results. Full disclaimer